Related Experiment Video
Updated: Jan 22, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Factors Predisposing to Hypertension in Subjects Formerly Born Preterm: Renal Impairment, Arterial Stiffness,
Antonio Crisafulli1, Pier P Bassareo2, Sean Kelleher2
1Department of Medical Sciences and Public Health, Sports Physiology Laboratory, University of Cagliari, Cagliari, Italy.
Insights
Individuals born preterm have a higher risk of developing arterial hypertension. This review explores mechanisms like reduced nephrons, arterial rigidity, and impaired nitric oxide pathways contributing to elevated blood pressure in preterm infants.
Area of Science:
- Cardiovascular Physiology
- Nephrology
- Developmental Pediatrics
Background:
- Individuals born preterm exhibit a higher incidence of arterial hypertension compared to term-born peers.
- This predisposition is linked to several physiological alterations originating during fetal development.
Purpose of the Study:
- To comprehensively review the multifactorial mechanisms underlying hypertension in individuals born preterm or with intrauterine growth restriction.
- To discuss emerging laboratory techniques for identifying metabolic alterations related to blood pressure regulation.
Main Methods:
- Literature review of studies investigating cardiovascular and renal development in preterm infants.
- Analysis of factors contributing to increased blood pressure, including nephrogenesis, arterial elasticity, and endothelial function.
- Exploration of the role of ADMA and the renin-angiotensin-aldosterone system.
Main Results:
- Incomplete nephrogenesis leads to fewer nephrons, reduced filtration, and increased sodium reabsorption.
- Elastin deficiency in the aorta contributes to arterial rigidity and elevated systolic blood pressure.
- Reduced nitric oxide bioavailability, exacerbated by elevated ADMA levels, promotes vasoconstriction.
Conclusions:
- Multiple developmental factors converge to increase hypertension risk in preterm individuals.
- Understanding these mechanisms is crucial for early detection and intervention strategies.
- Metabolomics offers a promising avenue for identifying novel biomarkers and therapeutic targets.
Abstract:
Subjects formerly born preterm subsequently develop arterial - particularly isolated systolic- hypertension more frequently than their peers born at term. Numerous factors may influence this predisposition, including an incomplete nephrogenesis, implying the presence of kidneys with a reduced number of nephrons and consequent reduction in haematic filtration, increased sodium absorption and activation of renin-angiotensin-aldosterone system, increased arterial rigidity produced by an elastin deficiency previously observed in anatomic specimens of human immature aorta, and reduced endothelial nitric oxide excretion, due to high blood levels of ADMA, a strong direct inhibitor of nitric oxide that exerts a vasoconstrictor effect. Other possible factors (i.e. excretion of neuroendocrine compounds) may also be implicated. The aim of this paper was to review all possible mechanisms involved in the observed increase in blood pressure in individuals who had been born preterm and/or with intrauterine growth restriction. The outlook for new and promising laboratory techniques capable of identifying alterations in the metabolic pathways regulating blood pressure levels, such as metabolomics, is also provided.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
The Born-Haber Cycle
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...

